Rank #1966GANX

Gain Therapeutics, Inc.

$1.89

3.28% (Daily)

Market Cap

$72.69M

Revenue

$N/A

Rank by MCap

#1966

Sector

Healthcare

Industry

Biotechnology

CEO

Dr. Khalid Islam Ph.D.

Headquarters

Bethesda, MD

Employees

About Gain Therapeutics, Inc.

Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia. Its drug discovery platform Magellan discovers novel allosteric binding sites in a disease; identifies proprietary small molecules that bind these sites to modulate protein function; and treats the underlying cause of the disease. The company's lead drug candidate is GT-02287, which is currently...